Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Composition SLU-PP-332: 5 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Evaluation of peptide impact on PGC-1 signaling and mitochondrial biogenesis Studies investigating potential roles in skeletal muscle metabolism models Development of in vitro and in vivo assays for metabolic pathway mapping Stability and solubility testing of SLU-PP-332 under various lab conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Nucalas manufacturer, GlaxoSmithKline (GSK), says the drugs list price is $3,689 for one dose, although the cost may vary based on dose and quantity
Third-party tested and 99% purity confirmed by in-house HPLC
The driver may be mast-cell-mediated or systemic rather than NF-B-local, and if so, increasing the dose for additional KPV will not address it see the mast-cell note under Phenotype Considerations
